n-methyl-3,4-methylenedioxyamphetamine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 13 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Millot, M | 1 |
| Saga, Y | 1 |
| Duperrier, S | 2 |
| Météreau, E | 2 |
| Beaudoin-Gobert, M | 2 |
| Sgambato, V | 1 |
| Thobois, S | 1 |
| Tremblay, L | 1 |
| Sgambato-Faure, V | 1 |
| Holden, C | 1 |
| Ricaurte, GA | 1 |
| Yuan, J | 1 |
| Hatzidimitriou, G | 1 |
| Cord, BJ | 1 |
| McCann, UD | 1 |
| Carmichael, M | 1 |
| Mithoefer, M | 1 |
| Jerome, L | 1 |
| Doblin, R | 1 |
| O'Shea, E | 1 |
| Colado, MI | 1 |
| Iravani, MM | 1 |
| Jackson, MJ | 1 |
| Kuoppamäki, M | 1 |
| Smith, LA | 1 |
| Jenner, P | 1 |
| Cosentino, C | 1 |
| Lebsanft, HB | 1 |
| Kohles, T | 1 |
| Kovar, KA | 1 |
| Schmidt, WJ | 1 |
| Leslie, M | 1 |
| Bishop, C | 1 |
| Taylor, JL | 1 |
| Kuhn, DM | 1 |
| Eskow, KL | 1 |
| Park, JY | 1 |
| Walker, PD | 1 |
| Smith, RM | 1 |
| Tivarus, M | 1 |
| Campbell, HL | 1 |
| Hillier, A | 1 |
| Beversdorf, DQ | 1 |
13 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys.
Topics: Animals; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Macaca fascicularis; Mal | 2020 |
Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Diffusion Tensor Imaging; Disease Mode | 2018 |
Neuroscience. Drug find could give ravers the jitters.
Topics: Animals; Axons; Brain; Clinical Trials as Topic; Dopamine; Hallucinogens; Haplorhini; Humans; Motor | 2002 |
RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Axons; Brain; Carrier Proteins; Corpus Str | 2002 |
A worry for ravers. One night of ecstasy could cause brain damage.
Topics: Adolescent; Brain Injuries; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Parkinsonian Disorders; | 2002 |
MDMA ("ecstasy") and neurotoxicity.
Topics: Animals; Brain; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hallucinogens; Haplorhini; Hu | 2003 |
Is frequent dosing with ecstasy a risky business for dopamine-containing neurons?
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Humans; N-Methyl-3,4-methylenedioxyamphetamine; | 2003 |
3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Calli | 2003 |
Ecstasy and acute dystonia.
Topics: Acute Disease; Adolescent; Adrenergic Uptake Inhibitors; Biperiden; Dose-Response Relationship, Drug | 2004 |
3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
Topics: Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Denervatio | 2005 |
Up to speed.
Topics: Amphetamines; Animals; Brain; Disease Models, Animal; Mice; N-Methyl-3,4-methylenedioxyamphetamine; | 2005 |
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dose-Respons | 2006 |
Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects.
Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Blinking; Cognition; Cognition Disorders; Extra | 2006 |